Note: The job is a remote job and is open to candidates in USA. Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with a mission to deliver on the promise of precision medicine through targeted radiation. The Director, Product Marketing – Upstream Late-Stage PSMA is responsible for shaping the commercial vision and lifecycle strategy for Telix’s late-stage PSMA imaging portfolio, ensuring optimal product positioning and alignment across teams.
Responsibilities
- Lead the development, refinement, and execution of commercial and lifecycle strategies for Illuccix®, Gozellix®, and late-stage PSMA programs
- Serve as the primary commercial thought leader guiding market evolution, competitive positioning, and long-range franchise strategy. Working closely with the Global Commercial PSMA team
- Build and steward a deep understanding of customer segments—including imaging centers, urology networks, and integrated specialty groups—to shape portfolio and pipeline decisions
- Partner with regional leaders and medical counterparts to proactively identify evidence needs and influence data-generation priorities
- Own the development and executive-level delivery of business cases, TAM/SAM analyses, value assessments, and lifecycle scenario modeling
- Collaborate with Commercial Strategy & Operations to pressure-test, align, and update late-stage forecasts and financial assumptions
- Anticipate market trends, competitive shifts, and adoption patterns to inform PMC submissions and investment decisions
- Convert complex commercial analyses into clear, strategic recommendations for regional leadership teams
- Act as the senior commercial partner to GDLs, ensuring late-stage development aligns with market needs, differentiation strategy, and launch readiness
- Lead cross-functional governance with Medical Affairs, Regulatory, Market Access, and Marketing Operations to ensure regional alignment across lifecycle activities
- Oversee commercial contributions to Launch Readiness Reviews (LRRs) and drive post-launch optimization frameworks
- Ensure a seamless upstream-to-downstream transition by aligning GTM strategy, messaging, and operational scaling across regions
- Oversee the synthesis of competitive intelligence, including clinical progress, regulatory events, launch timing, messaging, and technology advances
- Provide strategic insights that shape brand positioning, lifecycle prioritization, and risk mitigation plans
- Monitor policy, reimbursement, and market access shifts to anticipate barriers and opportunities for PSMA imaging adoption
- Lead high-impact strategic initiatives such as lifecycle indication launches, expansion projects, and multi-regional alignment activities
- Drive execution excellence by setting timelines, governance structures, and communication standards for cross-functional teams
- Present strategic updates, insights, and recommendations to executive leadership and participate in PMC and portfolio governance forums
Skills
- Bachelor's degree in Marketing, Business, or Life Sciences; MBA or advanced degree strongly preferred
- 8–12+ years of experience in pharmaceutical, biotech, molecular imaging, medical device or diagnostics marketing, ideally in oncology or urology
- Proven experience leading upstream product strategy, lifecycle management, or commercial planning for late-stage assets
- Strong ability to synthesize scientific, clinical, communicate commercial insights into strategic decision-making
- Demonstrated success influencing cross-functional teams in complex, matrixed environments
- Strong financial and analytical acumen, with experience developing sophisticated forecasts and investment cases
- Exceptional communication, executive presentation, and stakeholder leadership skills
- Advanced project leadership and organizational capabilities
Benefits
- Competitive salaries
- Annual performance-based bonuses
- An equity-based incentive program
- Generous vacation
- Paid wellness days
- Support for learning and development
- Hybrid and remote employees located all around the world
Company Overview
Telix is a global biopharmaceutical company focused on the development and commercialization of radiopharmaceuticals to address significant unmet medical need in oncology and rare diseases. It was founded in 2015, and is headquartered in Melbourne, Victoria, AUS, with a workforce of 1001-5000 employees. Its website is http://www.telixpharma.com.